文献速递妇产影像技术与安全

游离胎儿DNA在流产妇女中检测染色体异常的准确性:系统评价与Meta分析

Accuracy of cell-free fetal DNA in detecting chromosomal anomalies in women experiencing miscarriage: systematic review and meta-analysis.
PubMed 文献 · Ultrasound Obstet Gynecol · 2024-12-07

该系统评价与Meta分析纳入7项研究共887例流产妇女,以妊娠组织细胞遗传学分析为参考标准,评估cfDNA检测染色体异常的诊断准确性。cfDNA对21、18、13三体的敏感度和特异度均很高,对其他常染色体非整倍体和拷贝数变异的准确性仅为中等,检测失败率为7.3%。

要点

  • cfDNA对流产妇女21三体检测敏感度100%、特异度100%。
  • cfDNA对13三体敏感度88.9%、特异度100%,对18三体敏感度100%、特异度100%。
  • cfDNA检测失败率7.3%,判读报告时需注意检测失败可能。

核心结论

  • cfDNA在流产妇女中检测胎儿21、18、13三体具有高诊断准确性,对其他常染色体非整倍体和CNVs的准确性仅为中等。

研究设计与样本

  • 系统评价与Meta分析,检索PubMed、MEDLINE、EMBASE和Cochrane数据库至2024年6月,纳入7项研究共887例流产妇女(妊娠20周前流产),以妊娠组织细胞遗传学分析为参考标准,采用QUADAS修订工具评估研究质量,使用分层汇总受试者工作特征模型计算汇总估计值。

诊断标准与关键数值

  • 21三体:cfDNA敏感度100%(95%CI 81.5-100%),特异度100%(95%CI 99.1-100%)。
  • 18三体:cfDNA敏感度100%(95%CI 54.1-100%),特异度100%(95%CI 99.0-100%)。
  • 13三体:cfDNA敏感度88.9%(95%CI 51.8-99.7%),特异度100%(95%CI 99.1-100%)。
  • 其他常染色体三体:cfDNA敏感度75.8%(95%CI 65.7-84.2%),特异度99.4%(95%CI 97.9-99.9%)。
  • 拷贝数变异(CNVs):cfDNA敏感度60.0%(95%CI 14.7-94.7%),特异度100%(95%CI 97.4-100%)。

临床应用与阅片要点

  • cfDNA检测失败率为7.3%(95%CI 5.7-9.2%),报告时需注明检测失败的可能。
  • 对21、18、13三体,cfDNA敏感度和特异度均高,可作为流产染色体异常检测的参考。
  • 对其他常染色体非整倍体和CNVs,cfDNA敏感度中等,阴性结果不能排除异常。

局限性

  • 纳入研究数量较少(7项研究)。
  • 其他常染色体三体和CNVs的敏感度置信区间较宽。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To report the diagnostic accuracy of cell-free fetal DNA (cfDNA) in detecting fetal chromosomal anomalies in women experiencing miscarriage.

METHODS: PubMed, MEDLINE, EMBASE and Cochrane databases were searched from inception to June 2024. The inclusion criteria were women experiencing miscarriage (defined as pregnancy loss before 20 weeks of gestation) who underwent cfDNA screening for trisomies 21, 18 and 13, other autosomal aneuploidies, sex-chromosome aneuploidies and/or copy-number variants (CNVs). The index test was cfDNA screening for each of the chromosomal anomalies listed. The reference standard was cytogenetic analysis of pregnancy tissue. The quality of the studies was assessed using the revised tool for the quality assessment of diagnostic accuracy studies. Summary estimates of sensitivity, specificity, positive and negative likelihood ratios, and diagnostic odds ratio were computed using the hierarchical summary receiver-operating-characteristics model.

RESULTS: Seven studies (887 women) were included in the systematic review and meta-analysis. cfDNA had a sensitivity and specificity of 100% (95% CI, 81.5-100%) and 100% (95% CI, 99.1-100%), respectively, for trisomy 21, 100% (95% CI, 54.1-100%) and 100% (95% CI, 99.0-100%), respectively, for trisomy 18, and 88.9% (95% CI, 51.8-99.7%) and 100% (95% CI, 99.1-100%), respectively, for trisomy 13. The respective values for other autosomal trisomies were 75.8% (95% CI, 65.7-84.2%) and 99.4% (95% CI, 97.9-99.9%), while those for CNVs were 60.0% (95% CI, 14.7-94.7%) and 100% (95% CI, 97.4-100%). Failure of cfDNA testing was reported in 7.3% (95% CI, 5.7-9.2%) of cases.

CONCLUSION: cfDNA has high diagnostic accuracy in detecting fetal trisomies 21, 18 and 13 in women experiencing miscarriage, while its accuracy for other autosomal aneuploidies and CNVs is only moderate. © 2024 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Della Valle L, Piergianni M, Khalil A, et al. Accuracy of cell-free fetal DNA in detecting chromosomal anomalies in women experiencing miscarriage: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2024. PMID: 39644510. doi:10.1002/uog.29131

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。